Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06405828 · ClinicalTrials.gov registry record · NA
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
A NA study of Metastatic Breast Cancer and Stage IV Breast Cancer AJCC V7, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT06405828: Recruiting NA study of Metastatic Breast Cancer and Stage IV Breast Cancer AJCC V7, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06405828 is a NA study of Metastatic Breast Cancer and Stage IV Breast Cancer AJCC V7 that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 67 participants, below the 204-participant average among 139 other Metastatic Breast Cancer trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06405828, a NA study of Metastatic Breast Cancer and Stage IV Breast Cancer AJCC V7, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
Black and Latina women experience disparities in supportive and palliative care access and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and acceptability of a community navigator delivered supportive care intervention for historically underserved populations of women with metastatic breast cancer.
Primary Outcome
Acceptability evaluates if patients accept the intervention through the ability to recruit 60 participants in 1.5 years and a \<20% dropout rate at 9 months
Conditions Studied
Interventions
- BEHAVIORAL ACCESS Supportive Care
- BEHAVIORAL Phone sessions
Study Locations (1)
New York
- Mount Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What NCT06405828 shows while recruiting
NCT06405828 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 204-participant average among 139 other Metastatic Breast Cancer trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Metastatic Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which ACCESS Supportive Care is the first listed.
NCT06405828 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06405828 about?
NCT06405828 is a clinical study titled "Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer". Black and Latina women experience disparities in supportive and palliative care access and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and acceptability of a community navigator delivered supportive care intervention for historically underserved populations of women...
What is the current status of trial NCT06405828?
This trial is currently recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2024-05-01. Estimated completion is 2026-11-30.
What conditions does trial NCT06405828 study?
This clinical trial studies the following conditions: Metastatic Breast Cancer, Stage IV Breast Cancer AJCC V7.
What interventions are being tested in trial NCT06405828?
The interventions under investigation include: ACCESS Supportive Care (BEHAVIORAL), Phone sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06405828?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06405828 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06405828's enrollment target sits among peer trials
67 73rd of 139 higher than 67 of 139 other Metastatic Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metastatic Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
RECRUITING · NA
-
Adaptation of a Values Assessment Tool
RECRUITING · NA
-
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
RECRUITING · NA
-
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
RECRUITING · NA
-
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
RECRUITING · NA
-
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI